Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-26

Clinical Trial Update: Microvascular Dysfunction and the Development of Whole-body Insulin Resistance [NA]

View source ↗

Summary

A completed clinical trial from Amsterdam UMC investigated whether microvascular dysfunction contributes to the development of whole-body insulin resistance. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Amsterdam UMC, location VUmc | Conditions: Insulin Resistance, Type 2 Diabetes | NA | Status: COMPLETED